StonvexLoading…
StonvexStonvexStonvexCore line items from SNGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 | Q1 2021 2021-03-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $33.35K | $33.35K | $33.35K | $1.93M |
Operating Income | $-8.59M | $-5.22M | $-2.23M | $-18.59M |
Net Income | $-7.85M | $-4.26M | $-2.36M | $-17.69M |
EPS (Diluted) | $-0.20 | $-0.11 | $-0.06 | $-0.64 |
Total Assets | $29.72M | $29.61M | $31.55M | $19.89M |
Total Liabilities | $14.66M | $14.01M | $14.23M | $16.15M |
Cash & Equivalents | $28.87M | $28.98M | $30.54M | $18.68M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-11.46M |
Shares Outstanding | 42.63M | 40.08M | 40.02M | 30.64M |